Cost-effectiveness of hip protectors in institutional dwelling elderly

Osteoporosis International

Volumn 14, Issue 3, 2003, Pages 243-250

  Waldegger, Lisa ^a   Cranney, Ann ^c   Man Son Hing, Malcolm ^a,b   Coyle, Doug ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

Author keywords

Cost effectiveness; Elderly; Hip facture; Hip protectors; Meta analysis; Osteoporosis

Indexed keywords

ARTICLE; CANADA; CLINICAL TRIAL; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HEALTH ECONOMICS; HIP FRACTURE; HUMAN; INSTITUTIONAL CARE; META ANALYSIS; PRIORITY JOURNAL; PROBABILITY; PROTECTIVE EQUIPMENT; RISK ASSESSMENT;

AGED; COST-BENEFIT ANALYSIS; FEMALE; HIP FRACTURES; HUMANS; INSTITUTIONALIZATION; MALE; MONTE CARLO METHOD; PROTECTIVE DEVICES; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; RISK ASSESSMENT;

EID: 0142209468     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00198-002-1354-3     Document Type: Article

References (41)

1. Cooper C, Campion G, Melton LJ III (1992) Hip fractures in the elderly: a world-wide projection. Osteoporos Int 2(285):89
2. Gulberg B, Johnell O, Kanis J (1997). World-wide projections for hip fracture. Osteoporos Int 7(407):13
3. Chandler JM, Zimmerman SI, Cirman DJ, Martine AR, Hawkes W, Hebel R et al (2000) Low bone mineral density and risk of fracture in white female nursing home residents. JAMA 284:972-977
4. Papaioannou A, Wiktorowicz M, Adachi JD, Goeree R, Papadimitropoulos E, Bedard M et al (2000) Mortality, independence in living, and re-fracture, one year following hip fracture in Canadians. J Soc Obstet Gynaecol Can 22:591-597
5. Jagal S (1998) Osteoporosis fractures: incidence and impact. In: Badley E, Williams JI, editors. Patterns of health care in Ontario: arthritis and related conditions. North York: Institute for Clinical Evaluative Sciences, 143-156
6. Goeree R, O'Brien B, Pettitt D, Cuddy L, Ferraz M, Adachi J (1996) An assessment of the burden of illness due to osteoporosis in Canada. J Soc Obstet Gynaecol Can (Supplement):15-24
7. Hawker G (1998) Epidemiology of arthritis and osteoporosis. In: Badley E, Williams JI (eds) Patterns of health care in Ontario: arthritis and related conditions. Institute for Clinical Evaluative Sciences, North York, pp 1-10
8. Lauritzen JB, Petersen MM, Lund B (1993) Effect of external hip protectors on hip fractures. Lancet 341(8836):11-13
9. Rubenstein LA, Josephson KR, Robbins AS (1994) Falls in a nursing home. Ann Intern Med 121:442-451
10. Ooms ME, Vlasman P, Lips P, Nauta J, Bouter LM, Valkenburg HA (1994) The incidence of hip fractures in independent and institutionalized elderly people. Osteoporos Int 4(1):6-10
11. Parkkari J, Kannus P, Palvanen M, Natri A, Vainio J, Aho H et al (1999) Majority of hip fractures occur as a result of a fall and impact on the greater trochanter of the femur: a prospective controlled hip fracture study with 206 consecutive patients. Calcif Tissue Int 65:183-187
12. Greenspan SL, Myers ER, Kiel DP, Parker RA, Hayes WC, Resnick NM (1998) Fall direction, bone mineral density, and function: risk factors for hip fracture in frail nursing home elderly. Am J Med 104(6):539-545
13. Hayes WC, Myers ER, Morris JN, Gerhart TN, Yett H, Lipsitz LA (1993) Impact near the hip dominates fracture risk in elderly nursing home residents who fall. Calcif Tissue Int 52(3):192-198
14. Kannus P, Parkkari J, Niemi S, Pasanen M, Palvanen M, Jarvinen M et al (2000) Prevention of hip fracture in elderly people with use of a hip protector. N Engl J Med 343(21):1506-1513
15. Parkkari J, Kannus P, Heikkila J, Poutala J, Sievanen H, Vuori I (1995) Energy-shunting external hip protector attenuates the peak femoral impact force below the theoretical fracture threshold: an in vitro biomechanical study under falling conditions of the elderly. J Bone Miner Res 10(10):1437-1442
16. Kannus P, Parkkari J, Poutala J (1999) Comparison of force attenuation properties of four different hip protectors under simulated falling conditions in the elderly: an in vitro biomechanical study. Bone 25(2):229-235
17. Parker MJ, Gillespie LD, Gillespie WJ. Hip protectors for preventing hip fractures in the elderly (Cochrane Review). Cochrane Database of Systematic Reviews (computer file) 4:CD001255, 2000
18. Harada A, Mizuno M, Takemura M, Tokuda H, Okuizumi H, Niino N (2001) Hip fracture prevention trial using hip protectors in Japanese nursing homes. Osteoporos Int 12(3):215-221
19. Parker MJ, Gillespie LD, Gillespie WJ (2001) Hip protectors for preventing hip fractures in the elderly. Cochrane Database Syst Rev 2:CD001255
20. Coyle D, Cranney A, Lee KM, Welch V, Tugwell P (2001) Cost-effectiveness of nasal calcitonin in postmenopausal women: using Cochrane collaboration methods for meta analysis in economic evaluation. Pharmacoeconomics 19:565-575
21. CCOHTA (1997) Guidelines for economic evaluation of pharmaceuticals, 2d edn. CCOHTA, Ottawa
22. Papadimitropoulos E, Coyte PC, Josse RG, Greenwood CE (1997) Current and projected rates of hip fracture in Canada. CMAJ 157:1257-1363
23. Melton III LJ, Atkinson EJ, Cooper C, O'Fallon WM, Riggs BL (1999) Vertebral fractures predict subsequent fractures. Osteoporos Int 10(3):214-221
24. Statistics Canada (1995) Life Tables, Canada and Provinces, 1990-1992 (84-537 Occasional). Statistics Canada, Ottawa
25. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ (1985) Probabilistic sensitivity analysis using monte carlo simulation: a practical approach. Med Decis Making 5(2):157-177
26. Stinnett AA, Mullahy J (1998) Net health benefits: a framework for the analysis of uncertainty in cost-effective analysis. Med Decis Making 18(Suppl 2):S68-S80
27. Laupacis A, Feeny D, Tugwell PX (1992) How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 146(4):473-481
28. Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR (2000). Bayesian methods in health technology assessment: A review. Health Technol Assess 4(38):1-130
29. Harada A, Okuizumi H (1998) Hip fracture prevention trial using hip protector in Japanese elderly. Osteoporos Int 8(Suppl 3), 121
30. Buckler JE, Dutton TL, MacLeod HL, Manuge MB, Nixon MD. Use of hip protectors on a dementia unit. Physiother Can 310(49):297-299
31. Lauritzen JB, Hindso K, Petersen MM, Lund B (1996) Effect of hip protectors in falls on the hip and compliance. Osteoporosis 331-336
32. Heikinheimo RJ (2001) External hip protectors in the aged in institutions and home. Congress of the International Association of Gerontology
33. Chan DK, Hillier G, Coore M, Cooke R, Monk R, Mills J et al (2000) Effectiveness and acceptability of a newly designed hip protector: a pilot study. Arch Gerontol Geriatr 30(12):25-34
34. Ekman A, Mallmin H, Michaelsson K, Ljunghall S (1997) External hip protectors to prevent osteoporotic hip fractures. Lancet 350(9077):563-564
35. Jadad A, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12
36. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M et al (1998) Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 352(9128):609-613
37. Specht-Leible N, Oster P (1999) Hip fracture with correctly positioned external hip protector. Age Ageing 28(5):497
38. Cameron I, Kurrle S (1997) External hip protectors. J Am Geriatr Soc 45(9):1158
39. Villar M, Tracey A, Hill P, Inskip H, Thompson P, Cooper C (1998) Will elderly rest home residents wear hip protectors? Age Ageing 27(2):195-198
40. Hubacher M, Wettstein A (2001) Acceptance of hip protectors for hip fracture prevention in nursing homes. Osteoporosis Int 12:794-799
41. Haynes RB, McKibbon KA, Kanani R (1996) Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet 348: 383-386